Insider Stock Trading History of Rozenman Mary M.


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Rozenman Mary M. since year 2005. The trader's CIK number is 1648920. At the time of this reporting, Rozenman Mary M. is the See Remarks of Aimmune Therapeutics, Inc. . (stock ticker symbol AIMT). See this page for all insider trading activities at Aimmune Therapeutics, Inc. .


Stock purchases, sales, and option exercises reported by insider Rozenman Mary M. since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-09-07 AIMT Aimmune Therapeutics, Inc. Option Ex 30,000 3.02 90,660
2017-09-07 AIMT Aimmune Therapeutics, Inc. Sale 30,000 22.50 675,000
2017-07-17 AIMT Aimmune Therapeutics, Inc. Sale 300 21.38 6,414
2017-07-13 AIMT Aimmune Therapeutics, Inc. Option Ex 8,974 3.02 27,119
2017-07-14 AIMT Aimmune Therapeutics, Inc. Option Ex 5,666 3.02 17,122
2017-07-13 AIMT Aimmune Therapeutics, Inc. Sale 8,974 21.47 192,662
2017-07-14 AIMT Aimmune Therapeutics, Inc. Sale 5,666 21.39 121,173
2017-07-17 AIMT Aimmune Therapeutics, Inc. Option Ex 300 3.02 906
2017-07-05 AIMT Aimmune Therapeutics, Inc. Sale 15,060 21.39 322,208
2017-07-03 AIMT Aimmune Therapeutics, Inc. Option Ex 30,000 3.02 90,660
2017-07-03 AIMT Aimmune Therapeutics, Inc. Sale 30,000 20.57 617,190
2017-07-05 AIMT Aimmune Therapeutics, Inc. Option Ex 15,060 3.02 45,511
2016-11-04 AIMT Aimmune Therapeutics, Inc. Sale 24,096 17.60 424,089
2016-11-04 AIMT Aimmune Therapeutics, Inc. Option Ex 24,096 3.02 72,818
2016-10-05 AIMT Aimmune Therapeutics, Inc. Option Ex 25,000 3.02 75,550
2016-10-05 AIMT Aimmune Therapeutics, Inc. Sale 25,000 16.80 420,000
2016-09-08 AIMT Aimmune Therapeutics, Inc. Sale 30,000 16.80 504,000
2016-09-08 AIMT Aimmune Therapeutics, Inc. Option Ex 30,000 3.02 90,660

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Rozenman Mary M. (See Remarks of Aimmune Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.